Columbia University’s Mailman School of Public Health has released a new study showing that the EITC can be a highly cost-effective health policy investment. Researchers analyzed data from the 1993-2010 Behavioral Risk Factor Surveillance System surveys as well as state level life expectancy and determined the cost-effectiveness of state EITC supplements using a microsimulation model that estimates government costs and benefits to recipients. Findings showed that the program is more cost effective than many other health interventions and also has the potential to reverse mortality trends. The findings are published in the American Journal of Preventative Medicine.